These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32852645)

  • 21. Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.
    Aljanabi R; Alsous L; Sabbah DA; Gul HI; Gul M; Bardaweel SK
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach.
    Di Paolo ML; Cozza G; Milelli A; Zonta F; Sarno S; Minniti E; Ursini F; Rosini M; Minarini A
    FEBS J; 2019 Dec; 286(24):4995-5015. PubMed ID: 31291696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.
    Youdim MBH
    J Neural Transm (Vienna); 2018 Nov; 125(11):1719-1733. PubMed ID: 30341696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
    Rojas RJ; Edmondson DE; Almos T; Scott R; Massari ME
    Bioorg Med Chem; 2015 Feb; 23(4):770-8. PubMed ID: 25600407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics, mechanism, and inhibition of monoamine oxidase.
    Ramsay RR; Albreht A
    J Neural Transm (Vienna); 2018 Nov; 125(11):1659-1683. PubMed ID: 29516165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine oxidases in development.
    Wang CC; Billett E; Borchert A; Kuhn H; Ufer C
    Cell Mol Life Sci; 2013 Feb; 70(4):599-630. PubMed ID: 22782111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.
    Tripathi RKP; Ayyannan SR
    Med Res Rev; 2019 Sep; 39(5):1603-1706. PubMed ID: 30604512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
    Bainbridge JL; Page RL; Ruscin JM
    Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C6- and C7-Substituted 3,4-dihydro-2(1H)-quinolinones as Inhibitors of Monoamine Oxidase.
    Meiring L; Petzer JP; Petzer A
    Drug Res (Stuttg); 2017 Mar; 67(3):170-178. PubMed ID: 27926950
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E; Chodera A
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A need for clinical trial: re-purposing the Monoamine Oxidase Inhibitors (MAO-I) for rheumatoid arthritis (RA).
    Bala A
    Inflammopharmacology; 2023 Dec; 31(6):3367-3370. PubMed ID: 37558921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants.
    Herraiz T; Flores A; Fernández L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():136-144. PubMed ID: 29268246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders.
    Srivastava P; Sudevan ST; Thennavan A; Mathew B; Kanthlal SK
    CNS Neurol Disord Drug Targets; 2024; 23(3):331-341. PubMed ID: 36872357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors.
    Kumar S; Bhowmik R; Oh JM; Abdelgawad MA; Ghoneim MM; Al-Serwi RH; Kim H; Mathew B
    Sci Rep; 2024 Feb; 14(1):4868. PubMed ID: 38418571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.
    Behl T; Kaur D; Sehgal A; Singh S; Sharma N; Zengin G; Andronie-Cioara FL; Toma MM; Bungau S; Bumbu AG
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.